UnknownPhase 4ketamine

Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia

Sponsored by Hallym University Kangnam Sacred Heart Hospital

NCT ID
NCT02493231
Target Enrollment
60 participants
Start Date
2015-03

About This Study

Many anesthesiologists use the Remifentanil for reducing a surgical pain and stabilizing a vital sign. However, this drug induce postoperative hyperalgesia. Nowadays, many studies report that low-dose Ketamine prevents the opioid-induces hyperalgesia. Nefopam,which is non-opioid analgesic, has similar mechanism with Ketamine. It will be helpful for postoperative pain control, and reduce the needs of opioid.

Conditions Studied

Cholecystitis

Interventions

  • Nefopam
  • Ketamine
  • Saline

Eligibility

Age:20 Years - 65 Years
View full eligibility criteria
Inclusion Criteria:

* patient who scheduled laparoscopic cholecystectomy under general anesthesia
* American Society of Anesthesiologist(ASA) class I or II
* adult patient (age 20 - 65)

Exclusion Criteria:

* patient who has liver disease
* patient who has kidney disease
* patient who has diabetes mellitus(DM) or heart disease
* patient who takes opioid or beta-blocker
* patient who has airway disease
* patient who has allergy with the drug

Study Locations (1)

Hallym University Kangnam Sacred Heart Hospita
Seoul, South Korea

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

Effect of Intraoperative Nefopam on Acute Pain After Remifentanil Based Anesthesia | Huxley